#evaluate(de(' #AdditionalMetaTags# '))#
INOFEA was created to meet a critical need of the industry: to make enzymes more stable, re-usable and suitable for continuous processes.
We immobilize enzymes and protect them with a tailor-made shield, making them easy to use in biocatalysis, bioanalysis, proteomics and as an active ingredient. Our customers are among the top players in their industry, namely Pharma, Food & Feed, Specialty Chemicals and Consumer Care.
Our technology allows a reduction of raw materials needed for synthesis, a reduction of energy consumption during the production process and a reduction of waste and solvents in biocatalytic processes.
New executives to drive startup growth (startupticker.ch)
BAS members invested a 7-digit amount in start-ups in 2020 (startupticker.ch)
The EIT Food cohort of 2020 is ready for the acceleration journey (startupticker.ch)
Nine start-ups on a virtual stage (startupticker.ch)
INOFEA enters longterm collaboration with the global pharma company UCB (startupticker.ch)
INOFEA spins-off Perseo Pharma to further develop therapeutic enzymes (startupticker.ch)
From Tesla, Thomas Reuters and Schoeller to startups (startupticker.ch)
INOFEA closes 2nd tranche of Series A+ financing round (startupticker.ch)
INOFEA closes oversubscribed financing round (startupticker.ch)